nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

20.08.2021 | Research article

Rectal administration of buttermilk processed with medicinal plants alters gut microbiome in obese individuals

verfasst von: Sarika Mane, Kunal K. Dixit, Nidhi Lathwal, Dhiraj Dhotre, Priyadarshani Kadus, Yogesh S. Shouche, Supriya Bhalerao

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the effect of rectal administration of buttermilk processed with medicinal plants on gut microbial composition and thereby on weight in obese individuals.

Methods

With ethics committee approval, 16 obese individuals in the age group 20–50 years (BMI ≥30 kg/m²) were recruited who received a course of 15-enemas over 15-days. Of these, 1st, 8th and 15th enemas were of sesame-oil administered after food, while other enemas were of buttermilk processed with medicinal plants administered before food. Outcome variables viz. anthropometry, body composition, blood glucose, insulin and lipid profile were evaluated on day 0, 16 and 45. Also, microbial composition of buttermilk preparation and faecal samples of patients collected on day 0, 16 and 45 were studied with the help of 16S rRNA gene sequencing.

Results

The circumferential measures and skinfold-thickness showed a decrease on day 16, which remained lower as compared to baseline till day 45. A gradual decrease in blood-glucose was seen, which was statistically significant on day 45, while insulin levels increased on day 16 and fell to baseline on day 45. There was an overall increase in bacterial diversity on day 16 that settled back to its original composition by day 45.

Conclusion

Our findings suggest that buttermilk administration per rectum is effective for a specific period and may have to be repeated for sustained benefits.

Nur mit Berechtigung zugänglich

Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17.https://doi.org/10.1007/978-3-319-48382-5_1.

Heiss CN, Olofsson LE. Gut microbiota-dependent modulation of energy metabolism. J Innate Immun. 2018;10(3):163–71. https://doi.org/10.1159/000481519.CrossRefPubMed

Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GA, Gasbarrini A, Mele MC. What is the healthy gut microbiota composition? a changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14. https://doi.org/10.3390/microorganisms7010014.

Crommen S, Simon MC. Microbial regulation of glucose metabolism and insulin resistance. Genes (Basel). 2018;9(1):16–22. https://doi.org/10.3390/genes9010010.CrossRef

Tai N, Wong FS, Wen L. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord. 2015;16(1):55–65. https://doi.org/10.1007/s11154-015-9309-0.CrossRefPubMedPubMedCentral

Patil DP, Dhotre DP, Chavan SG, Sultan A, Jain DS, Lanjekar VB, Gangawani J, Shah PS, Todkar JS, Shah S, Ranade DR, Patole MS, Shouche YS. Molecular analysis of gut microbiota in obesity among Indian individuals. J Biosci. 2012;37(4):647–57. https://doi.org/10.1007/s12038-012-9244-0.

Gonzalez S, Fernandez-Navarro T, Arboleya S, De Los Reyes-Gavilan CG, Salazar N, Gueimonde M. Fermented dairy foods: impact on intestinal microbiota and health-linked biomarkers. Front Microbiol. 2019;10. https://doi.org/10.3389/fmicb.2019.01046.

Jayashree S, Pushpanathan M, Rajendhran J, Gunasekaran P. Microbial diversity and phylogeny analysis of buttermilk, a fermented Milk product, employing 16S rRNA-based pyrosequencing. Food Biotechnol. 2013;27(3):213–21. https://doi.org/10.1080/08905436.2013.811084.CrossRef

Chaudhari D, Dhotre D, Agarwal D, Gondhali A, Nagarkar A, Lad V, Patil U, Juvekar S, Sinkar V, Shouche Y. Understanding the association between the human gut, oral and skin microbiome and the Ayurvedic concept of prakriti. J Biosci. 2019;44(5):1–8. https://doi.org/10.1007/s12038-019-9939-6.

10.

Chauhan NS, Pandey R, Mondal AK, Gupta S, Verma MK, Jain S, Ahmed V, Patil R, Agarwal D, Girase B, Shrivastava A, Mobeen F, Sharma V, Srivastava TP, Juvekar SK, Prasher B, Mukerji M, Dash D. Western Indian rural gut microbial diversity in extreme Prakriti endo-phenotypes reveals signature microbes. Front Microbiol. 2018;9:118. https://doi.org/10.3389/fmicb.2018.00118.

11.

Steer E. A cross comparison between Ayurvedic etiology of major depressive disorder and bidirectional effect of gut dysregulation. J Ayurveda Integr Med. 2019;10(1):59–66. https://doi.org/10.1016/j.jaim.2017.08.002.CrossRefPubMedPubMedCentral

12.

Aswathy Y, Anandaraman P. Therapeutic influence of some dietary articles on gut microbiota in the pathogenesis of rheumatoid arthritis (Amavata) – a review. AYU. 2019;40(3):147. https://doi.org/10.4103/ayu.ayu_192_19.

13.

Mallikarjun, Channabasavanna BM. Srinivasulu. A clinical study on Takra Basti in the management og grahani W.S.R To I.B.S. prayeshana. Int J Ayu Res. 2017;2(2)26–34.

14.

Gupte P, Harke S, Deo V, Bhushan Shrikhande B, Mahajan M, Bhalerao S. A clinical study to evaluate the efficacy of herbal formulation for obesity (HFO-02) in overweight individuals. J Ayurveda Integr Med. 2020;11(2):159–62. https://doi.org/10.1016/j.jaim.2019.05.003.CrossRefPubMed

15.

Thatte U, Chiplunkar S, Bhalerao S, Kulkarni A, Ghungralkar R, Panchal F, Vetale S, Teli P, Kumbhar D, Munshi R. Immunological & metabolic responses to a therapeutic course of Basti in obesity. Indian J Med Res. 2015;142:53–62. https://doi.org/10.4103/0971-5916.162099.

16.

Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017;45(W1):W180–8. https://doi.org/10.1093/nar/gkx295.CrossRefPubMedPubMedCentral

17.

Zhang J, Kobert K, Flouri T, Stamatakis A. PEAR: a fast and accurate Illumina paired-end reAd mergeR. Bioinformatics. 2014;30(5):614–20. https://doi.org/10.1093/bioinformatics/btt593.CrossRefPubMed

18.

Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–3. https://doi.org/10.1038/nmeth.3869.CrossRefPubMedPubMedCentral

19.

Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(D1):590–6. https://doi.org/10.1093/nar/gks1219.CrossRef

20.

Iwai S, Weinmaier T, Schmidt BL, Albertson DG, Poloso NJ, Dabbagh K, Desantis T. Piphillin: improved prediction of metagenomic content by direct inference from human microbiomes. PLoS One 2016;11(11):1–18. https://doi.org/10.1371/journal.pone.0166104.

21.

Kho ZY, Lal SK. The human gut microbiome - a potential controller of wellness and disease. Front Microbiol. 2018;9:1–23. https://doi.org/10.3389/fmicb.2018.01835.

22.

Rezac S, Kok CR, Heermann M, Hutkins R. Fermented foods as a dietary source of live organisms. Front Microbiol. 2018;9. https://doi.org/10.3389/fmicb.2018.01785.

23.

George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: a review. J Food Drug Anal. 2018;26(3):927–39. https://doi.org/10.1016/j.jfda.2018.01.002.CrossRefPubMed

24.

Barukcic I, Jakopovic KL, Bozanic R. Valorisation of whey and buttermilk for production of functional beverages - an overview of current possibilities. Food Technol Biotechnol. 2019;57(4):448–60. https://doi.org/10.17113/ftb.57.04.19.6460.

25.

Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity Committee of the Council on nutrition. Physical Circulation. 2006;113(6):898–918. https://doi.org/10.1161/CIRCULATIONAHA.106.171016.

26.

Lee YH, Lee HW, Choi HJ. GLP-1 based combination therapy for obesity and diabetes. J Obes Metab Syndr. 2017;26(3):155–60. https://doi.org/10.7570/jomes.2017.26.3.155.CrossRefPubMedPubMedCentral

27.

Cornejo-Pareja I, Martín-Núñez GM, Roca-Rodríguez MM, Cardona F, Coin-Aragüez L, Sánchez-Alcoholado L, Gutiérrez-Repiso C, Muñoz-Garach A, Fernández-García JC, Moreno-Indias I, Tinahones FJ. H. pylori eradication treatment alters gut microbiota and GLP-1 secretion in humans. J Clin Med. 2019;8(4):451. https://doi.org/10.3390/jcm8040451.

28.

Hossain FB, Shawon SR, Adhikary G, Chowdhury A. Association between body mass index (BMI) and hypertension in South Asian population: evidence from demographic and health survey. Clin Hypertens. 2019;25:28. https://doi.org/10.1101/605469.

29.

Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, Sánchez-Margalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci. 2020;21(16):1–24. https://doi.org/10.3390/ijms21165887.CrossRef

30.

Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes. 2008;32(11):1720–4. https://doi.org/10.1038/ijo.2008.155.CrossRef

31.

Nadal I, Santacruz A, Marcos A, Warnberg J, Garagorri JM, Moreno LA, Martin-Matillas M, Campoy C, Martí A, Moleres A, Delgado M, Veiga OL, García-Fuentes M, Redondo CG, Sanz Y. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes. 2009;33(7):758–67. https://doi.org/10.1038/ijo.2008.260.

32.

Tims S, Derom C, Jonkers DM, Vlietinck R, Saris WH, Kleerebezem M, et al. Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J. 2013;7(4):707–17. https://doi.org/10.1038/ismej.2012.146.CrossRefPubMed

33.

Koliada A, Syzenko G, Moseiko V, Budovska L, Puchkov K, Perederiy V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17(1):4–9. https://doi.org/10.1186/s12866-017-1027-1.CrossRef

34.

Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity [Internet]. 2010;18(1):190–5. https://doi.org/10.1038/oby.2009.167.CrossRef

35.

Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. 2020;12(5)1474. https://doi.org/10.3390/nu12051474.

36.

Donohoe DR, Garge N, Zhang X, Sun W, O’Connell TM, Bunger MK, et al. Microbiome, the regulate, butyrate metabolism. Energy Cell Metab. 2011;13(5):517–26. https://doi.org/10.1016/j.cmet.2011.02.018.CrossRefPubMed

37.

Litvak Y, Byndloss MX, Bäumler AJ. Colonocyte metabolism shapes the gut microbiota single sentence summary. Science. 2018;36(6418). https://doi.org/10.1126/science.aat9076.

38.

Jun X, Chen HB, Li SL. Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota. Med Res Rev. 2017;37(5):1140–185. https://doi.org/10.1002/med.21431.

39.

Lu YM, Xie JJ, Peng CG, Wang BH, Wang KC, Li LJ. Enhancing clinical efficacy through the gut microbiota: a new field of traditional Chinese medicine. Engineering. 2019;5(1):40–9. https://doi.org/10.1016/j.eng.2018.11.013.CrossRef

Titel: Rectal administration of buttermilk processed with medicinal plants alters gut microbiome in obese individuals
verfasst von: Sarika Mane
Kunal K. Dixit
Nidhi Lathwal
Dhiraj Dhotre
Priyadarshani Kadus
Yogesh S. Shouche
Supriya Bhalerao
Publikationsdatum: 20.08.2021
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2021
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-021-00879-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Die Leitlinien für Ärztinnen und Ärzte, Digitale Mammographien links in kraniokaudaler Projektion./© Weigel, S. et al. / all rights reserved Springer Medizin Verlag GmbH, Operation bei Blasenkrebs/© anistidesign / Fotolia, Medizinische Fachangestellte sitzt erschöpft auf der Treppe/© Courtney Haas / peopleimages.com /stock.adobe.com (Symbolbild mit Fotomodell), Mann wird von Ärztin untersucht/© Tashi-Delek, Getty Images, iStock (Symbolbild mit Fotomodellen)

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Neuroprotective effect of Bauhinia variegata Linn. leaf extracts in streptozotocin induced diabetes in Sprague Dawley rats

The association between muscle indicators and bone mass density and related risk factors in the diabetic elderly population: Bushehr Elderly Health (BEH) Program

Trend and pattern of using herbal medicines among people who are aware of their diabetes mellitus: results from National STEPs Surveys in 2005 to 2011 in Iran

Body impedance analyzer and anthropometric indicators; predictors of metabolic syndrome

Glycemic control outcome in patients with type 2 diabetes mellitus: chronic care management support of family care team in Thailand